cbdMD, Inc. income statement YCBD

In fiscal 2025, which ended Sep 30, 2025, cbdMD, Inc. reported revenue of $19.2 million, down 3.7% from the year before. It recorded a net loss of $2.0 million. The operating loss came to $2.2 million, an operating margin of -11.3%. Diluted earnings per share were -$1.09. Over the twelve months ended Jun 30, 2026, revenue was $20.9 million and the net loss was $2.9 million. Across the 9 fiscal years shown, revenue grew from $4.5 million in fiscal 2017 to $19.2 million in fiscal 2025, about 20.0% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Sep 30, 2025
FY 2024
Sep 30, 2024
FY 2023
Sep 30, 2023
FY 2022
Sep 30, 2022
FY 2021
Sep 30, 2021
FY 2020
Sep 30, 2020
FY 2019
Sep 30, 2019
FY 2018
Sep 30, 2018
FY 2017
Sep 30, 2017
Revenue
21
+10.0%
19
-3.7%
20
-20.5%
25
-32.5%
37
-16.5%
44
+6.2%
42
+77.1%
24
+5051.8%
0
-89.7%
4
Cost of revenue
9
+20.0%
7
-3.5%
7
-18.4%
9
-29.8%
13
-9.9%
14
-6.6%
16
+69.8%
9
+8684.4%
0
-92.3%
1
Gross profit
12
+3.7%
12
-0.2%
12
-19.9%
15
-32.9%
22
-25.5%
30
+13.7%
26
+81.7%
15
+3987.8%
0
-88.6%
3
Operating income
-3
-61.9%
-2
+34.8%
-3
+85.3%
-22
+71.3%
-78
-299.0%
-20
-11.6%
-18
-18.8%
-15
-723.4%
-2
-32.0%
-1
Pretax income
-3
-90.8%
-2
+44.8%
-4
+83.9%
-23
+67.3%
-70
-188.5%
-24
-314.8%
11
+123.7%
-48
—
—
Income tax
—
0
0
0
0
+100.0%
-1
-166.5%
1
+157.0%
-2
0
-100.0%
0
Net income
-3
-90.8%
-2
+44.8%
-4
+83.9%
-23
+67.3%
-70
-199.6%
-23
-285.6%
13
+124.5%
-51
-81835.3%
0
+104.5%
-1
Net income to common
-3
+36.5%
-4
+43.2%
-8
+71.4%
-27
+63.6%
-74
-185.5%
-26
-312.1%
12
+124.3%
-50
-12137.6%
-0
+76.3%
-2
Basic EPS
-0.32
+86.8%
-1.09
+92.4%
-14.29
-7.3%
-13.32
+76.1%
-55.80
-11772.3%
-0.47
-267.9%
0.28
+109.9%
-2.82
—
—
Diluted EPS
—
-1.09
+92.4%
-14.29
-7.3%
-13.32
+76.1%
-55.80
-11772.3%
-0.47
-267.9%
0.28
0.00
—
—
Weighted average shares, basic
10
+382.6%
4
+646.2%
1
-73.3%
2
+52.3%
1
-97.6%
55
+24.5%
44
+146.8%
18
—
—
Weighted average shares, diluted
—
4
+646.2%
1
-73.3%
2
+52.3%
1
-97.6%
55
+21.6%
45
+152.5%
18
—
—
Other measures
Depreciation and amortization
0
-46.4%
0
-20.2%
0
+11.9%
0
-57.4%
1
-6.7%
1
+41.2%
1
+148.9%
0
+30.1%
0
+212.2%
0
EBITDA
-3
-92.9%
-2
+37.1%
-3
+87.0%
-22
+71.4%
-77
-315.7%
-19
-10.3%
-17
-16.2%
-15
-821.4%
-2
-22.1%
-1
Interest coverage
—
—
—
—
—
—
—
—
-1,881.75x
-2.72x
Margins
Gross margin
57.68%
62.36%
60.21%
59.78%
60.17%
67.41%
62.96%
61.37%
77.34%
69.71%
Operating margin
-13.87%
-11.27%
-16.64%
-89.76%
-210.83%
-44.10%
-41.98%
-62.56%
-391.44%
-30.42%
Pretax margin
-13.80%
-10.63%
-18.57%
-91.56%
-188.79%
-54.61%
26.99%
-202.05%
—
—
Profit margin
-13.80%
-10.63%
-18.57%
-91.56%
-188.79%
-52.60%
30.09%
-217.14%
13.69%
-30.98%
EBITDA margin
-12.85%
-9.39%
-14.37%
-88.14%
-208.28%
-41.81%
-40.26%
-61.34%
-342.97%
-28.82%
Effective tax rate
—
—
—
—
—
—
11.90%
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
Listed as
YCBD (NYSE)
Fiscal year ends
September 30
Incorporated in
NC
Headquarters
Charlotte, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1644903
Former names
Level Brands, Inc. (until May 1, 2019); LEVEL BEAUTY GROUP, INC. (until Sep 27, 2016)

Other Perfumes, Cosmetics & Other Toilet Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.